Exegenesis Bio

Last Updated May 8, 2025

Company Overview

Company Name

Exegenesis Bio

About Exegenesis Bio

Exegenesis Bio is a clinical-stage global cell and gene therapy company founded in 2019 with strong financial backing. The company has built a broad pipeline of innovative genetic medicines and fully integrated manufacturing capabilities, focused on the development of gene therapies for central nervous system, ophthalmology, and liver diseases.

Frequently Asked Questions about Exegenesis Bio

Social Profiles

Key Decision Makers

Zhenhua Wu CEO
LinkedIn
Meghan Wedeking Clinical Trials and Regulatory Associate
LinkedIn